Sica, Simona
 Distribuzione geografica
Continente #
NA - Nord America 17.661
AS - Asia 13.668
EU - Europa 11.994
SA - Sud America 2.779
AF - Africa 448
OC - Oceania 214
Continente sconosciuto - Info sul continente non disponibili 18
Totale 46.782
Nazione #
US - Stati Uniti d'America 17.043
SG - Singapore 6.163
CN - Cina 2.962
DE - Germania 2.737
IT - Italia 2.496
BR - Brasile 2.228
SE - Svezia 1.755
FR - Francia 1.172
VN - Vietnam 1.149
GB - Regno Unito 753
IN - India 655
IE - Irlanda 637
UA - Ucraina 558
ID - Indonesia 462
JP - Giappone 387
BD - Bangladesh 381
FI - Finlandia 356
CA - Canada 348
RU - Federazione Russa 323
HK - Hong Kong 286
AR - Argentina 213
NL - Olanda 201
ES - Italia 198
PL - Polonia 196
KR - Corea 190
AU - Australia 188
TR - Turchia 186
IQ - Iraq 168
MX - Messico 157
ZA - Sudafrica 102
AT - Austria 86
SA - Arabia Saudita 77
EC - Ecuador 76
IR - Iran 70
BE - Belgio 67
PK - Pakistan 65
CO - Colombia 63
CI - Costa d'Avorio 60
CZ - Repubblica Ceca 58
VE - Venezuela 58
EG - Egitto 53
MA - Marocco 53
CH - Svizzera 51
UZ - Uzbekistan 49
KE - Kenya 46
RO - Romania 46
PH - Filippine 41
TH - Thailandia 39
CL - Cile 38
HU - Ungheria 35
NP - Nepal 35
PT - Portogallo 35
PY - Paraguay 35
BG - Bulgaria 34
MY - Malesia 34
AE - Emirati Arabi Uniti 33
IL - Israele 32
DZ - Algeria 31
JO - Giordania 29
TW - Taiwan 28
LT - Lituania 27
NO - Norvegia 27
UY - Uruguay 26
NZ - Nuova Zelanda 24
PE - Perù 24
LB - Libano 23
AZ - Azerbaigian 21
JM - Giamaica 20
TN - Tunisia 20
GR - Grecia 19
KZ - Kazakistan 18
SK - Slovacchia (Repubblica Slovacca) 18
ET - Etiopia 17
RS - Serbia 17
TT - Trinidad e Tobago 15
DO - Repubblica Dominicana 14
BO - Bolivia 13
HR - Croazia 12
PA - Panama 12
SN - Senegal 12
AL - Albania 11
BA - Bosnia-Erzegovina 11
AO - Angola 10
HN - Honduras 10
OM - Oman 10
DK - Danimarca 9
MD - Moldavia 9
AM - Armenia 8
BZ - Belize 8
CR - Costa Rica 8
KG - Kirghizistan 8
PR - Porto Rico 8
QA - Qatar 8
GE - Georgia 7
LK - Sri Lanka 7
LY - Libia 7
BY - Bielorussia 6
EU - Europa 6
GA - Gabon 6
SI - Slovenia 6
Totale 46.649
Città #
Singapore 3.067
Ashburn 1.742
San Jose 1.623
Chandler 1.542
Dublin 621
Beijing 593
Los Angeles 466
Rome 420
Milan 418
Jacksonville 411
Jakarta 409
Lauterbourg 390
Ho Chi Minh City 369
San Mateo 369
New York 364
Hefei 342
Wilmington 312
Hanoi 310
Dearborn 304
Tokyo 294
Woodbridge 275
Ann Arbor 267
Nanjing 256
Houston 252
Hong Kong 248
Frankfurt am Main 246
Boston 240
Munich 233
Dallas 222
Chicago 212
São Paulo 207
Moscow 200
Redwood City 199
Hyderabad 193
Princeton 189
Seattle 189
Cattolica 174
Buffalo 173
Council Bluffs 166
Fairfield 161
St Louis 145
The Dalles 142
Lancaster 139
Santa Clara 139
Nürnberg 130
Boardman 126
Helsinki 124
Lawrence 120
Marseille 116
Redmond 114
Toronto 114
Oviedo 112
Seoul 112
Nanchang 110
Warsaw 110
Orem 101
Kent 99
Hangzhou 94
Paris 94
Brooklyn 87
Bremen 84
London 78
Izmir 75
Atlanta 74
San Francisco 74
Florence 71
Shanghai 69
Phoenix 68
Tianjin 66
Amsterdam 64
Baghdad 63
Brussels 62
Da Nang 62
Rio de Janeiro 62
Lappeenranta 61
Abidjan 60
Norwalk 60
Mountain View 59
Naples 59
Nuremberg 58
Chennai 54
Curitiba 54
Belo Horizonte 53
Guangzhou 53
Johannesburg 53
Denver 51
Cambridge 49
Kunming 49
Washington 49
Hebei 47
Mexico City 47
Montreal 47
Manchester 46
Shenyang 46
Charlotte 44
Pune 44
Dhaka 43
Melbourne 42
Tashkent 42
Zhengzhou 42
Totale 23.280
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.668
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 432
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 382
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 332
Dasatinib first-line: Multicentric Italian experience outside clinical trials 295
Dasatinib first-line: Multicentric Italian experience outside clinical trials 294
comparison of haploidentical bone marrow versus matchet unrelated donor peripheral blood stem cell transplantation with posttransplant cyclophosphamide in patients with acute leukemia 292
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 290
days alive outside hospital and readmissions in patients undergoing allogenic transpalnts from identical siblings or alternative donors 278
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 236
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs 231
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 230
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 221
Correlation between paraproteinaemia and viral reactivation after allo-SCT 216
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 214
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 211
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 202
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 202
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 196
Outcomes of Off the Shelf Outer Branched Versus Inner Branched Endografts in the Treatment of Thoraco-Abdominal Aortic Aneurysm in the B.R.I.O. (BRanched Inner – Outer) Study Group 193
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 193
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 191
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 190
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 189
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 188
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 185
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 181
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 179
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 179
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 177
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 176
Clonal evolution in therapy-related neoplasms 176
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 174
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 173
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 170
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 169
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 169
Work related acute leukemia and mucor mycosis in a boat-builder 168
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 166
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 166
The sac evolution imaging follow-up after endovascular aortic repair: An international expert opinion-based Delphi consensus study 164
Hyperleukocytosis and leukostasis: management of a medical emergency 162
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 161
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 160
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 159
Neurologic improvement after peripheral blood stem cell transplantation in poems 159
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 158
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 158
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 157
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 157
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 156
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 155
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 154
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 153
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 153
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 152
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 152
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 151
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 151
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 151
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 151
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 150
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 149
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 149
MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings 148
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Endovascular Stent-Graft Repair of True and False Aneurysms of the Splenic Artery 146
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Hyperleukocytosis and leukostasis: management of a medical emergency 146
Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation 146
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 146
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 146
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 141
CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia 140
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 139
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 139
BCR-ABL1 compound mutants prevalence spectrum and correlation with tyrosine kinase inibitor resistance in a consecutive series of philadelphia chromosome-positive leukemia patients analyzed by NGS 139
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 138
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 137
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 137
Autologus stem cell transplantation as bridging rherapy followed by CD19 Car-T cells in relapsed refractory large B cell lymphoma 137
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 136
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab 136
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 134
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 133
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 132
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 132
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 132
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 132
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 131
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation 130
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 129
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 129
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 128
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 128
Totale 20.944
Categoria #
all - tutte 197.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/20222.628 249 128 75 139 162 78 66 390 140 179 507 515
2022/20235.174 754 661 414 708 373 621 263 337 571 183 196 93
2023/20244.039 124 853 194 210 218 561 243 157 165 271 499 544
2024/20258.340 429 341 649 566 591 289 323 348 1.116 793 1.591 1.304
2025/202618.829 2.735 631 1.220 1.771 2.638 904 3.019 1.042 1.322 1.469 994 1.084
Totale 47.556